| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/11/2002 | US6403792 Sulfonyl isatin compounds and methods of blocking apoptosis therewith |
| 06/11/2002 | US6403791 Treatment of inflammatory diseases or autoimmune diseases in humans or animals |
| 06/11/2002 | US6403790 Suspending and dissolving epinastine base in water by adding aqueous hydrochloric acid at specified ph, extracting solution obtained with organic water-immiscible solvent, removing solvent, adjusting ph to precipitate product, drying |
| 06/11/2002 | US6403786 Compounds used to label, detect and sequence nucleic acids |
| 06/11/2002 | US6403759 Polymers for delivering nitric oxide in vivo |
| 06/11/2002 | US6403758 Bioresorbable compositions for implantable prostheses |
| 06/11/2002 | US6403658 N-methyl nicotinate |
| 06/11/2002 | US6403657 Citalopram and phenteramine |
| 06/11/2002 | US6403656 Skin disorders |
| 06/11/2002 | US6403655 Method of preventing adhesions with absorbable polyoxaesters |
| 06/11/2002 | US6403653 Active topical skin protectants using reactive nanoparticles |
| 06/11/2002 | US6403652 Method and composition |
| 06/11/2002 | US6403651 Mediation of circadian rhythms |
| 06/11/2002 | US6403650 Treatment of pulmonary hypertension |
| 06/11/2002 | US6403649 Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 06/11/2002 | US6403648 Alkylaminoalkyl-sulfonyl-terminated β-alanineamide amino-diol compounds for treatment of hypertension |
| 06/11/2002 | US6403647 Pulsed administration of compositions for the treatment of blood disorders |
| 06/11/2002 | US6403646 Method for the treatment of alpha-1-antitrypsin deficiency and related pathologies |
| 06/11/2002 | US6403645 Antidepressant effect of norepinephrine uptake 2 inhibitors and combined medications including them |
| 06/11/2002 | US6403643 Use of 2,5-dihydroxybenzenesulfonic derivatives for the normalization of endothelial function |
| 06/11/2002 | US6403641 Treating a human for obesity comprises administering to the patient a compound of formula n-(1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl)-n,n-dimethy lamine or a salt and an oxetane compound |
| 06/11/2002 | US6403640 Method for treating chronic prostatitis or chronic pelvic pain syndrome |
| 06/11/2002 | US6403639 2,3-dihydrobenzofuran derivatives |
| 06/11/2002 | US6403638 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 06/11/2002 | US6403637 Administering 3-hydroxy-3-methylglutaryl coenzyme a (hmg-coa) reductase inhibitors to increase endocytosis of collagenase-3; used to treat arthritis and other degenerative joint diseases |
| 06/11/2002 | US6403636 Xanthone compounds, their preparation and use as medicament |
| 06/11/2002 | US6403635 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 06/11/2002 | US6403634 For treating abnormal cell proliferation |
| 06/11/2002 | US6403631 Method and compositions for enhancing pregnancy success in an animal |
| 06/11/2002 | US6403630 Administering a cyclooxygenase-2 (cox-2) inhibitor alone or in combination with herceptin? antibody; used to treat breast cancer |
| 06/11/2002 | US6403629 Heterocyclic compounds for therapeutic use |
| 06/11/2002 | US6403627 For treatment of dysfunctions and disease conditions arising from oxidative damage; phenyl n-tert-butylnitrone derivatives |
| 06/11/2002 | US6403624 8,8A-dihydroindeno[1,2-D] thiazole derivatives which are substituted in the 8A-position; processes for their preparation and their use as medicaments |
| 06/11/2002 | US6403623 Administering 2-(2-substituted-phenyl)-2-oxazolines and related 5-membered heterocycles |
| 06/11/2002 | US6403619 Method for controlling cell necrosis or apoptosis |
| 06/11/2002 | US6403618 Administering picolinic acid derivatives to chelate with zinc and iron in proteins; antiangiogenic and antineoplastic agent |
| 06/11/2002 | US6403617 Including human cytomegalovirus, herpes simplex viruses, epstein-barr virus, varicella-zoster virus, humanherpesviruses-6 and -7, and kaposi herpesvirus |
| 06/11/2002 | US6403616 Chemical process and pharmaceutical formulation |
| 06/11/2002 | US6403615 Treats osteoporosis, hyperlipidemia, and cardiovascular disorders associated with menopause; side effect reduction compared to estrogen-replacement therapy |
| 06/11/2002 | US6403614 Such as 2-(4-(methylthiomethoxy)phenyl)-3-(4-(2-piperidin-1-yl)ethoxy) benzoyl)-6-methylthiomethoxybenzo(b)thiophene;inhibition of osteoporosis, hyperlipedemia, cancer, postmenopausal syndrome, |
| 06/11/2002 | US6403613 Anti-inflammatory agent that reduces levels of cytokines (including tumor necrosis factor) |
| 06/11/2002 | US6403611 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/11/2002 | US6403609 Topical-use lubricant that gels when administered to the eye |
| 06/11/2002 | US6403608 3-Substituted isoquinolin-1-yl derivatives |
| 06/11/2002 | US6403607 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 06/11/2002 | US6403606 Antiinflammatory, antiarthritis, a drug for inhibiting bone resorption, immunosuppressant |
| 06/11/2002 | US6403605 Apomorphine |
| 06/11/2002 | US6403604 Nitrogen-based camptothecin derivatives |
| 06/11/2002 | US6403603 Antitumor agent |
| 06/11/2002 | US6403602 Morphine-6-sulfate analogues and their use for the treatment of pain |
| 06/11/2002 | US6403601 N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (NK1) and/or neurokinin 2 (NK2) receptor antagonists |
| 06/11/2002 | US6403599 Corticotropin releasing factor antagonists |
| 06/11/2002 | US6403598 Ophthalmic composition |
| 06/11/2002 | US6403597 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
| 06/11/2002 | US6403592 Serotonin reuptake inhibitors |
| 06/11/2002 | US6403591 1-azatricyclic-4-benzylpiperazines |
| 06/11/2002 | US6403590 Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia |
| 06/11/2002 | US6403589 Nucleoside transport inhibitor |
| 06/11/2002 | US6403588 Imidazopyridine derivatives |
| 06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
| 06/11/2002 | US6403586 Interleukin inhibitors |
| 06/11/2002 | US6403583 Anticoagulant agents for treatment and prevention of thromboembolic disorders. |
| 06/11/2002 | US6403581 Method of inhibition of farnesyl-protein transferase using substituted benz (cd) indol-2-imine and-amine derivatives |
| 06/11/2002 | US6403580 Having an inhibitory effect on signal transduction mediated by tyrosine kinases, the use thereof for treating diseases, particularly tumoral diseases, diseases of the lungs and respiratory tract, and the preparation thereof. |
| 06/11/2002 | US6403579 Treating cardiac and cardiovascular disorders and the illnesses associated therewith, hypertension, angina pectoris, cardiac insufficiency |
| 06/11/2002 | US6403578 Anticoagulants, cardiovascular disorders |
| 06/11/2002 | US6403577 Hexamethyleneiminyl tachykinin receptor antagonists |
| 06/11/2002 | US6403576 Antifungal and antiparasitic compounds |
| 06/11/2002 | US6403575 3-Pyridyl enantiomers and their use as analgesics |
| 06/11/2002 | US6403574 Tranquilizers, antiepileptic, muscle relaxation prior to surgery |
| 06/11/2002 | US6403573 Compounds of azetidine and pyrrolidin |
| 06/11/2002 | US6403570 Method of curing an injury to a skin surface |
| 06/11/2002 | US6403569 Therapeutically synergistic, particularly colorectal cancer; campto? (cpt-11, irinotecan), and folinic acid |
| 06/11/2002 | US6403567 To stimulate mammalian coronary vasodilatation and for imaging the heart; regadenoson |
| 06/11/2002 | US6403566 Conformationally locked; antiviral, anticancer, stability to cellular nucleases and strong binding affinity to nucleic acid targets. |
| 06/11/2002 | US6403565 Enhances dna repair and prevents consequences of mutagenic radiation even when administered after damage or exposure to radiation has already occurred; deoxyribonucleosides: deoxycytidine, deoxyadenosine, deoxyguanosine, and thymidine. |
| 06/11/2002 | US6403563 Antineoplastic topoisomerase i inhibitor |
| 06/11/2002 | US6403561 Disorders associated with the inactivation or excessive degradation of cholecystokinin; inhibiting the enzymatic hydrolysis of cholecystokinin 1-(2(s)-aminobutyryl)-2(s)-indolinecarboxylic acid |
| 06/11/2002 | US6403560 Extracting hyaluronic acid together with a protein from chicken comb, mammalian skin or mammalian organ; |
| 06/11/2002 | US6403558 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis |
| 06/11/2002 | US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics |
| 06/11/2002 | US6403347 Chaetochromins produced from mf6252 fungi culture; viricides, antibiotics, immunomodulators, and vaccines |
| 06/11/2002 | US6403345 Culturing, fermentation, obtaining biomass; purification; foods, drugs, cosmetics |
| 06/11/2002 | US6403335 Amino acid sequence; promotes survival of mesencephalic cells; nervous system and degenerative disorders; parkinson*s disease; genetic engineering |
| 06/11/2002 | US6403318 Fatty acid synthase mRNA binding protein |
| 06/11/2002 | US6403125 Pronounced action on lipolysis so useful in slimming preparations, but also owing to their tightening effect, their smoothing properties and the improvement of the radiance of the skin. |
| 06/11/2002 | US6403123 Topical application of anthralin that results in minimal or no staining of skin or clothing; applying a wax formulation over the involved area |
| 06/11/2002 | US6403122 Bioavailability based on a lipolytic indifferent vehicle, an absorption promoter and active n-methylated cyclic undecapeptides or macrolide lactones; self assembly drug delivery system (sadds); cyclosporins |
| 06/11/2002 | US6403121 Of a biquamide, metformin, and coating of pioglitazone hydrochloride; modulating release polymer comprising a polysaccharide, alginate; antidiabetic |
| 06/11/2002 | US6403120 Extended release formulation of venlafaxine hydrochloride |
| 06/11/2002 | US6403117 Archaesomes, archaeosomes containing coenzyme Q10 and other types of liposomes containing coenzyme Q10 adjuvants and as delivery vehicles |
| 06/11/2002 | US6403116 Dimethyl sulfone, citric acid, and at least one polysorbate; dietary supplement; stable dispersions in aqueous medium for oral administration |
| 06/11/2002 | US6403114 Having a reduced level of residual solvent(s); controlled-release microparticles having improved shelf-life |
| 06/11/2002 | US6403112 Ectoin and ectoin derivatives as moisturizers in cosmetics |
| 06/11/2002 | US6403110 Topical treatment for oily skin |
| 06/11/2002 | US6403094 Clostridium perfringens vaccines |
| 06/11/2002 | US6403089 Inhibitors of fgl2; bacterial and viral infections, allograft and xenograft rejection, glomerulonephritis, cancer, gastrointestinal diseases and fetal loss; monoclonal and polyclonal antibodies which bind to fgl2 and prevent fibrin |
| 06/11/2002 | US6403087 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological disease |
| 06/11/2002 | US6403086 Administering extracts of morinda citrifolia, red wine, prune, blueberry, pomegranate, apple and an enzyme mixture |
| 06/11/2002 | US6403083 Antitumor, anticancer agents; mixture containing mycelium and carrier |